Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1996 Dec;70(12):8727–8736. doi: 10.1128/jvi.70.12.8727-8736.1996

Imbalanced expression of glutamate-glutamine cycle enzymes induced by human T-cell lymphotropic virus type 1 Tax protein in cultivated astrocytes.

H Akaoka 1, H Hardin-Pouzet 1, A Bernard 1, B Verrier 1, M F Belin 1, P Giraudon 1
PMCID: PMC190968  PMID: 8971000

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) is the etiological agent involved in the disease HTLV-1-associated myelopathy, or tropical spastic paraparesis (HAM/TSP). The pathogenesis of HAM/TSP is poorly understood, but it is probable that viral infection has an indirect, deleterious effect on neural function. In this regard, dysfunction in astrocytes may be severely detrimental, as they supply neurons with metabolic precursors, control the extracellular levels of ion and excitatory neurotransmitters, and are electrically coupled with oligodendrocytes. In a model in vitro, we demonstrate that HTLV-1 induces an imbalance in the expression of two astrocyte enzymes, at both the transcriptional and translational levels. In both human astrocyte precursors and rat glial cells, the levels of expression of glutamine synthetase (GS) and glutamate dehydrogenase (GDH) were increased and decreased, respectively, after coculture with HTLV-1 T cells. The enhancement of GS expression may result from the action of the protein Tax, which is demonstrated to transactivate the GS gene promoter, while the decreased expression of GDH seems to reflect some compensatory mechanism in response to GS induction. GS and GDH are involved in the conversion of glutamate into glutamine or alpha-ketoglutarate, which then acts as a precursor for glutamatergic and gamma-aminobutyric acid (GABA)-ergic neurons. Metabolism in astrocytes altered by Tax protein may lead to deleterious effects if it modifies the extracellular levels of glutamine, glutamate, and GABA and thus modulates neuronal excitability and osmotic equilibrium in the central nervous system of HTLV-1-infected patients.

Full Text

The Full Text of this article is available as a PDF (990.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexandre C., Charnay P., Verrier B. Transactivation of Krox-20 and Krox-24 promoters by the HTLV-1 Tax protein through common regulatory elements. Oncogene. 1991 Oct;6(10):1851–1857. [PubMed] [Google Scholar]
  2. Alexandre C., Verrier B. Four regulatory elements in the human c-fos promoter mediate transactivation by HTLV-1 Tax protein. Oncogene. 1991 Apr;6(4):543–551. [PubMed] [Google Scholar]
  3. Alliot F., Pessac B. Astrocytic cell clones derived from established cultures of 8-day postnatal mouse cerebella. Brain Res. 1984 Jul 23;306(1-2):283–291. doi: 10.1016/0006-8993(84)90377-9. [DOI] [PubMed] [Google Scholar]
  4. Armstrong A. P., Franklin A. A., Uittenbogaard M. N., Giebler H. A., Nyborg J. K. Pleiotropic effect of the human T-cell leukemia virus Tax protein on the DNA binding activity of eukaryotic transcription factors. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7303–7307. doi: 10.1073/pnas.90.15.7303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Baranger A. M., Palmer C. R., Hamm M. K., Giebler H. A., Brauweiler A., Nyborg J. K., Schepartz A. Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax. Nature. 1995 Aug 17;376(6541):606–608. doi: 10.1038/376606a0. [DOI] [PubMed] [Google Scholar]
  6. Battaglioli G., Martin D. L. GABA synthesis in brain slices is dependent on glutamine produced in astrocytes. Neurochem Res. 1991 Feb;16(2):151–156. doi: 10.1007/BF00965703. [DOI] [PubMed] [Google Scholar]
  7. Beimling P., Moelling K. Isolation and characterization of the tax protein of HTLV-I. Oncogene. 1989 Apr;4(4):511–516. [PubMed] [Google Scholar]
  8. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  9. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol. 1987 Aug;7(8):2745–2752. doi: 10.1128/mcb.7.8.2745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  11. Cross S. L., Feinberg M. B., Wolf J. B., Holbrook N. J., Wong-Staal F., Leonard W. J. Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell. 1987 Apr 10;49(1):47–56. doi: 10.1016/0092-8674(87)90754-9. [DOI] [PubMed] [Google Scholar]
  12. Das A. T., Arnberg A. C., Malingré H., Moerer P., Charles R., Moorman A. F., Lamers W. H. Isolation and characterization of the rat gene encoding glutamate dehydrogenase. Eur J Biochem. 1993 Feb 1;211(3):795–803. doi: 10.1111/j.1432-1033.1993.tb17611.x. [DOI] [PubMed] [Google Scholar]
  13. Dennis S. C., Clark J. B. The pathway of glutamate metabolism in rat brain mitochondria. Biochem J. 1977 Dec 15;168(3):521–527. doi: 10.1042/bj1680521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Duyao M. P., Kessler D. J., Spicer D. B., Bartholomew C., Cleveland J. L., Siekevitz M., Sonenshein G. E. Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B. J Biol Chem. 1992 Aug 15;267(23):16288–16291. [PubMed] [Google Scholar]
  15. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985 Aug 24;2(8452):407–410. doi: 10.1016/s0140-6736(85)92734-5. [DOI] [PubMed] [Google Scholar]
  16. Giam C. Z., Xu Y. L. HTLV-I tax gene product activates transcription via pre-existing cellular factors and cAMP responsive element. J Biol Chem. 1989 Sep 15;264(26):15236–15241. [PubMed] [Google Scholar]
  17. Giraudon P., Bernard A., Malcus C., Dufay N., Desgranges C., Belin M. F. Retroviral infection (HTLV-I) induces cytokine-regulated immunomodulation and cytotoxicity of medulloblastoma cells. J Neuropathol Exp Neurol. 1995 Mar;54(2):165–174. doi: 10.1097/00005072-199503000-00003. [DOI] [PubMed] [Google Scholar]
  18. Giraudon P., Dufay N., Hardin H., Reboul A., Tardy M., Belin M. F. Differentiation of a medulloblastoma cell line towards an astrocytic lineage using the human T lymphotropic retrovirus-1. Neuroscience. 1993 Feb;52(4):1069–1079. doi: 10.1016/0306-4522(93)90553-r. [DOI] [PubMed] [Google Scholar]
  19. Giraudon P., Thomasset N., Bernard A., Verrier B., Belin M. F. Induction of MMP9 (92 kDa gelatinase) activity and expression of tissue inhibitor of metalloproteinase-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-I. Eur J Neurosci. 1995 May 1;7(5):841–848. doi: 10.1111/j.1460-9568.1995.tb01071.x. [DOI] [PubMed] [Google Scholar]
  20. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Greene D. A., Sima A. A., Stevens M. J., Feldman E. L., Lattimer S. A. Complications: neuropathy, pathogenetic considerations. Diabetes Care. 1992 Dec;15(12):1902–1925. doi: 10.2337/diacare.15.12.1902. [DOI] [PubMed] [Google Scholar]
  22. Hardin-Pouzet H., Giraudon P., Belin M. F., Didier-Bazes M. Glucocorticoid upregulation of glutamate dehydrogenase gene expression in vitro in astrocytes. Brain Res Mol Brain Res. 1996 Apr;37(1-2):324–328. doi: 10.1016/0169-328x(95)00327-o. [DOI] [PubMed] [Google Scholar]
  23. Hawkins R. A., Jessy J., Mans A. M., De Joseph M. R. Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy. J Neurochem. 1993 Mar;60(3):1000–1006. doi: 10.1111/j.1471-4159.1993.tb03247.x. [DOI] [PubMed] [Google Scholar]
  24. Hertz L., Yu A. C., Schousboe A. Uptake and metabolism of malate in neurons and astrocytes in primary cultures. J Neurosci Res. 1992 Oct;33(2):289–296. doi: 10.1002/jnr.490330212. [DOI] [PubMed] [Google Scholar]
  25. Höllsberg P., Hafler D. A. What is the pathogenesis of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis? Ann Neurol. 1995 Feb;37(2):143–145. doi: 10.1002/ana.410370203. [DOI] [PubMed] [Google Scholar]
  26. Ijichi S., Izumo S., Eiraku N., Machigashira K., Kubota R., Nagai M., Ikegami N., Kashio N., Umehara F., Maruyama I. An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP. Med Hypotheses. 1993 Dec;41(6):542–547. doi: 10.1016/0306-9877(93)90111-3. [DOI] [PubMed] [Google Scholar]
  27. Jacobson S., McFarlin D. E., Robinson S., Voskuhl R., Martin R., Brewah A., Newell A. J., Koenig S. HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease. Ann Neurol. 1992 Nov;32(5):651–657. doi: 10.1002/ana.410320508. [DOI] [PubMed] [Google Scholar]
  28. Jacobson S., Shida H., McFarlin D. E., Fauci A. S., Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990 Nov 15;348(6298):245–248. doi: 10.1038/348245a0. [DOI] [PubMed] [Google Scholar]
  29. Jeang K. T., Widen S. G., Semmes O. J., 4th, Wilson S. H. HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science. 1990 Mar 2;247(4946):1082–1084. doi: 10.1126/science.2309119. [DOI] [PubMed] [Google Scholar]
  30. Jennings M. T., Jennings D. L., Ebrahim S. A., Johnson M. D., Turc-Carel C., Philip T., Philip I., Lapras C., Shapiro J. R. In vitro karyotypic and immunophenotypic characterisation of primitive neuroectodermal tumours: similarities to malignant gliomas. Eur J Cancer. 1992;28A(4-5):762–766. doi: 10.1016/0959-8049(92)90111-e. [DOI] [PubMed] [Google Scholar]
  31. Johnson R. T. Questions and prospects related to HIV-1 and the brain. Res Publ Assoc Res Nerv Ment Dis. 1994;72:311–323. [PubMed] [Google Scholar]
  32. Kaneko T., Shigemoto R., Mizuno N. Metabolism of glutamate and ammonia in astrocyte: an immunocytochemical study. Brain Res. 1988 Aug 2;457(1):160–164. doi: 10.1016/0006-8993(88)90069-8. [DOI] [PubMed] [Google Scholar]
  33. Kira J., Goto I., Otsuka M., Ichiya Y. Chronic progressive spinocerebellar syndrome associated with antibodies to human T-lymphotropic virus type I: clinico-virological and magnetic resonance imaging studies. J Neurol Sci. 1993 Mar;115(1):111–116. doi: 10.1016/0022-510x(93)90075-a. [DOI] [PubMed] [Google Scholar]
  34. Kira J., Itoyama Y., Koyanagi Y., Tateishi J., Kishikawa M., Akizuki S., Kobayashi I., Toki N., Sueishi K., Sato H. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol. 1992 Jan;31(1):39–45. doi: 10.1002/ana.410310108. [DOI] [PubMed] [Google Scholar]
  35. Kira J., Koyanagi Y., Yamada T., Itoyama Y., Tateishi J., Akizuki S., Kishikawa M., Baba E., Nakamura M., Suzuki J. Sequence heterogeneity of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol. 1994 Aug;36(2):149–156. doi: 10.1002/ana.410360206. [DOI] [PubMed] [Google Scholar]
  36. Kubota R., Umehara F., Izumo S., Ijichi S., Matsumuro K., Yashiki S., Fujiyoshi T., Sonoda S., Osame M. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J Neuroimmunol. 1994 Aug;53(1):23–29. doi: 10.1016/0165-5728(94)90060-4. [DOI] [PubMed] [Google Scholar]
  37. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  38. Lehky T. J., Fox C. H., Koenig S., Levin M. C., Flerlage N., Izumo S., Sato E., Raine C. S., Osame M., Jacobson S. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol. 1995 Feb;37(2):167–175. doi: 10.1002/ana.410370206. [DOI] [PubMed] [Google Scholar]
  39. Leung K., Nabel G. J. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature. 1988 Jun 23;333(6175):776–778. doi: 10.1038/333776a0. [DOI] [PubMed] [Google Scholar]
  40. Macchi B., Caronti B., Cocchia D., Gremo F., Torelli S., Sogos V., Bonmassar E., Lauro G. M. Correlation between P19 presence and MHC class II expression in human fetal astroglial cells cocultured with HTLV-I donor cells. Int J Dev Neurosci. 1992 Jun;10(3):231–241. doi: 10.1016/0736-5748(92)90063-6. [DOI] [PubMed] [Google Scholar]
  41. Magistretti P. J. Regulation of glycogenolysis by neurotransmitters in the central nervous system. Diabete Metab. 1988 May-Jun;14(3):237–246. [PubMed] [Google Scholar]
  42. Major M., Daenke S., Nightingale S., Desselberger U. Differential Tax expression in HTLV type I-infected asymptomatic carriers. AIDS Res Hum Retroviruses. 1995 Mar;11(3):415–421. doi: 10.1089/aid.1995.11.415. [DOI] [PubMed] [Google Scholar]
  43. Martin D. L. Synthesis and release of neuroactive substances by glial cells. Glia. 1992;5(2):81–94. doi: 10.1002/glia.440050202. [DOI] [PubMed] [Google Scholar]
  44. McKay R., Renfranz P., Cunningham M. Immortalized stem cells from the central nervous system. C R Acad Sci III. 1993 Dec;316(12):1452–1457. [PubMed] [Google Scholar]
  45. McKinnon E., Hargittai P. T., Grossfeld R. M., Lieberman E. M. Glutamine cycle enzymes in the crayfish giant nerve fiber: implications for axon-to-glia signaling. Glia. 1995 Jul;14(3):198–208. doi: 10.1002/glia.440140305. [DOI] [PubMed] [Google Scholar]
  46. Mill J. F., Mearow K. M., Purohit H. J., Haleem-Smith H., King R., Freese E. Cloning and functional characterization of the rat glutamine synthetase gene. Brain Res Mol Brain Res. 1991 Feb;9(3):197–207. doi: 10.1016/0169-328x(91)90003-g. [DOI] [PubMed] [Google Scholar]
  47. Miller S., Nunn P. B., Bridges R. J. Induction of astrocyte glutamine synthetase activity by the Lathyrus toxin beta-N-oxalyl-L-alpha,beta-diaminopropionic acid (beta-L-ODAP). Glia. 1993 Apr;7(4):329–336. doi: 10.1002/glia.440070408. [DOI] [PubMed] [Google Scholar]
  48. Mohler K. M., Butler L. D. Quantitation of cytokine mRNA levels utilizing the reverse transcriptase-polymerase chain reaction following primary antigen-specific sensitization in vivo--I. Verification of linearity, reproducibility and specificity. Mol Immunol. 1991 Apr-May;28(4-5):437–447. doi: 10.1016/0161-5890(91)90157-f. [DOI] [PubMed] [Google Scholar]
  49. Nicklas W. J. Amino acid metabolism in the central nervous system: role of glutamate dehydrogenase. Adv Neurol. 1984;41:245–253. [PubMed] [Google Scholar]
  50. Niewiesk S., Daenke S., Parker C. E., Taylor G., Weber J., Nightingale S., Bangham C. R. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol. 1995 Apr;69(4):2649–2653. doi: 10.1128/jvi.69.4.2649-2653.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Nimer S. Tax responsiveness of the GM-CSF promoter is mediated by mitogen-inducible sequences other than kappa B. New Biol. 1991 Oct;3(10):997–1004. [PubMed] [Google Scholar]
  52. Oldstone M. B. HIV neurons and cytotoxic T lymphocytes. Concepts about the AIDS dementia complex and viral persistence. Res Publ Assoc Res Nerv Ment Dis. 1994;72:89–97. [PubMed] [Google Scholar]
  53. Oldstone M. B. Rous-Whipple Award Lecture. Viruses and diseases of the twenty-first century. Am J Pathol. 1993 Nov;143(5):1241–1249. [PMC free article] [PubMed] [Google Scholar]
  54. Oldstone M. B. Viral alteration of cell function. Sci Am. 1989 Aug;261(2):42–48. doi: 10.1038/scientificamerican0889-42. [DOI] [PubMed] [Google Scholar]
  55. Olney J. W., Ho O. L., Rhee V. Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp Brain Res. 1971;14(1):61–76. doi: 10.1007/BF00234911. [DOI] [PubMed] [Google Scholar]
  56. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986 May 3;1(8488):1031–1032. doi: 10.1016/s0140-6736(86)91298-5. [DOI] [PubMed] [Google Scholar]
  57. Parker C. E., Nightingale S., Taylor G. P., Weber J., Bangham C. R. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J Virol. 1994 May;68(5):2860–2868. doi: 10.1128/jvi.68.5.2860-2868.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Paul N. L., Lenardo M. J., Novak K. D., Sarr T., Tang W. L., Ruddle N. H. Lymphotoxin activation by human T-cell leukemia virus type I-infected cell lines: role for NF-kappa B. J Virol. 1990 Nov;64(11):5412–5419. doi: 10.1128/jvi.64.11.5412-5419.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Perini G., Wagner S., Green M. R. Recognition of bZIP proteins by the human T-cell leukaemia virus transactivator Tax. Nature. 1995 Aug 17;376(6541):602–605. doi: 10.1038/376602a0. [DOI] [PubMed] [Google Scholar]
  60. Plaitakis A., Nicklas W. J., Desnick R. J. Glutamate dehydrogenase deficiency in three patients with spinocerebellar syndrome. Ann Neurol. 1980 Apr;7(4):297–303. doi: 10.1002/ana.410070403. [DOI] [PubMed] [Google Scholar]
  61. Popovic M., Lange-Wantzin G., Sarin P. S., Mann D., Gallo R. C. Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5402–5406. doi: 10.1073/pnas.80.17.5402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984 May 4;224(4648):497–500. doi: 10.1126/science.6200935. [DOI] [PubMed] [Google Scholar]
  63. Ransom B. R., Kettenmann H. Electrical coupling, without dye coupling, between mammalian astrocytes and oligodendrocytes in cell culture. Glia. 1990;3(4):258–266. doi: 10.1002/glia.440030405. [DOI] [PubMed] [Google Scholar]
  64. Rattner A., Korner M., Rosen H., Baeuerle P. A., Citri Y. Nuclear factor kappa B activates proenkephalin transcription in T lymphocytes. Mol Cell Biol. 1991 Feb;11(2):1017–1022. doi: 10.1128/mcb.11.2.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Renjifo B., Borrero I., Essex M. Tax mutation associated with tropical spastic paraparesis/human T-cell leukemia virus type I-associated myelopathy. J Virol. 1995 Apr;69(4):2611–2616. doi: 10.1128/jvi.69.4.2611-2616.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Richardson J. H., Edwards A. J., Cruickshank J. K., Rudge P., Dalgleish A. G. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol. 1990 Nov;64(11):5682–5687. doi: 10.1128/jvi.64.11.5682-5687.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Salahuddin S. Z., Markham P. D., Wong-Staal F., Franchini G., Kalyanaraman V. S., Gallo R. C. Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology. 1983 Aug;129(1):51–64. doi: 10.1016/0042-6822(83)90395-1. [DOI] [PubMed] [Google Scholar]
  68. Schousboe A., Westergaard N., Sonnewald U., Petersen S. B., Huang R., Peng L., Hertz L. Glutamate and glutamine metabolism and compartmentation in astrocytes. Dev Neurosci. 1993;15(3-5):359–366. doi: 10.1159/000111356. [DOI] [PubMed] [Google Scholar]
  69. Seiki M., Inoue J., Takeda T., Hikikoshi A., Sato M., Yoshida M. The p40x of human T-cell leukemia virus type I is a trans-acting activator of viral gene transcription. Jpn J Cancer Res. 1985 Dec;76(12):1127–1131. [PubMed] [Google Scholar]
  70. Shank R. P., Aprison M. H. Present status and significance of the glutamine cycle in neural tissues. Life Sci. 1981 Feb 23;28(8):837–842. doi: 10.1016/0024-3205(81)90044-8. [DOI] [PubMed] [Google Scholar]
  71. Sodroski J. G., Rosen C. A., Haseltine W. A. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science. 1984 Jul 27;225(4660):381–385. doi: 10.1126/science.6330891. [DOI] [PubMed] [Google Scholar]
  72. Sonnewald U., Westergaard N., Krane J., Unsgård G., Petersen S. B., Schousboe A. First direct demonstration of preferential release of citrate from astrocytes using [13C]NMR spectroscopy of cultured neurons and astrocytes. Neurosci Lett. 1991 Jul 22;128(2):235–239. doi: 10.1016/0304-3940(91)90268-x. [DOI] [PubMed] [Google Scholar]
  73. Sonnewald U., Westergaard N., Petersen S. B., Unsgård G., Schousboe A. Metabolism of [U-13C]glutamate in astrocytes studied by 13C NMR spectroscopy: incorporation of more label into lactate than into glutamine demonstrates the importance of the tricarboxylic acid cycle. J Neurochem. 1993 Sep;61(3):1179–1182. doi: 10.1111/j.1471-4159.1993.tb03641.x. [DOI] [PubMed] [Google Scholar]
  74. Spencer P. S., Allen C. N., Kisby G. E., Ludolph A. C., Ross S. M., Roy D. N. Lathyrism and western Pacific amyotrophic lateral sclerosis: etiology of short and long latency motor system disorders. Adv Neurol. 1991;56:287–299. [PubMed] [Google Scholar]
  75. Subbalakshmi G. Y., Murthy C. R. Effects of methionine sulfoximine on the enzymes of glutamate metabolism in isolated astrocytes of rat brain. Biochem Pharmacol. 1983 Dec 15;32(24):3695–3700. doi: 10.1016/0006-2952(83)90137-5. [DOI] [PubMed] [Google Scholar]
  76. Takahashi H., Koehler R. C., Brusilow S. W., Traystman R. J. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol. 1991 Sep;261(3 Pt 2):H825–H829. doi: 10.1152/ajpheart.1991.261.3.H825. [DOI] [PubMed] [Google Scholar]
  77. Umehara F., Izumo S., Nakagawa M., Ronquillo A. T., Takahashi K., Matsumuro K., Sato E., Osame M. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1993 Jul;52(4):424–430. doi: 10.1097/00005072-199307000-00010. [DOI] [PubMed] [Google Scholar]
  78. Umehara F., Izumo S., Ronquillo A. T., Matsumuro K., Sato E., Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1994 Jan;53(1):72–77. doi: 10.1097/00005072-199401000-00009. [DOI] [PubMed] [Google Scholar]
  79. Wagner S., Green M. R. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science. 1993 Oct 15;262(5132):395–399. doi: 10.1126/science.8211160. [DOI] [PubMed] [Google Scholar]
  80. Walz W. Role of glial cells in the regulation of the brain ion microenvironment. Prog Neurobiol. 1989;33(4):309–333. doi: 10.1016/0301-0082(89)90005-1. [DOI] [PubMed] [Google Scholar]
  81. Waniewski R. A. Physiological levels of ammonia regulate glutamine synthesis from extracellular glutamate in astrocyte cultures. J Neurochem. 1992 Jan;58(1):167–174. doi: 10.1111/j.1471-4159.1992.tb09292.x. [DOI] [PubMed] [Google Scholar]
  82. Yamada M., Watabe K., Saida T., Kim S. U. Increased susceptibility of human fetal astrocytes to human T-lymphotropic virus type I in culture. J Neuropathol Exp Neurol. 1991 Mar;50(2):97–107. doi: 10.1097/00005072-199103000-00001. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES